The National Institutes of Health often makes government-owned inventions available for licensing to expedite commercialization of federally funded research.

An invention available now is a computerized method of predicting kidney tumor growth for early stage treatment planning, the NIH announced Sept. 26 in a notice in the Federal Register. The method includes a 3-D prediction system using longitudinal kidney tumor images, with tissues classified into three types.

"The technique was tested on two longitudinal studies with seven time points on five tumors," according to the notice. "The experimental results (average of 91.4% true positive volume fraction and 4.0% of false positive volume fraction) showed the feasibility and efficacy of the technique."

The invention, developed at the NIH Clinical Center, a research hospital in Bethesda, Md., can be implemented in the oncology package that most major imaging companies have in their commercial workstation.

 

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access